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Description

Over the millennia, the human body and microorganisms such as bacteria, viruses, archaea,
protozoa and parasites have coevolved together forming an intimate relationship. These
microorganisms are found on the skin, in the mouth, genitourinary tract and most abundantly in the large intestine of the digestive tract. States of microbial dysbiosis contribute
to chronic inflammation, which can lead to the pathogenesis and progression of numerous
diseases. Micro- and macro-nutrients as well as dietary patterns like the Mediterranean diet
can help improve health outcomes.
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Introduction

The intestinal tract contains roughly a hundred
trillion microorganisms, including more than
1,000 species and over 7,000 strains, collectively termed the gut microbiota.1 Research has
only just begun to realize the potential for gut
health to promote overall health. The purpose
of this brief review is to outline the integral
relationship between the gut microbiota and
the immune inflammatory response, as well as
to highlight the viability of nutritional interventions to treat a host of chronic illnesses.

Inflammation

The inflammatory response is paramount in
maintaining innate immunity. Chemical messengers, called cytokines, play one role in this
complex system. These signaling molecules
are released primarily from macrophages and
dendritic cells, but also from T-lymphocytes,
natural killer cells, endothelial cells and mucosal
epithelial cells. Once secreted, they bind to target cells and depending on the type, will either
promote or attenuate inflammation.

With trillions of microorganisms, roughly 80%
of the immune system resides in the human
gut. The identification of specific bacterial
species within the microbiota that may prevent
or promote inflammation can elucidate the capacity for gut health to promote overall health.
A number of individual strains have been shown
to reduce inflammation. Lactobacillus and
Bifidobacterium reduce inflammation by promoting anti-inflammatory cytokines; Faecalibacterium prausnitzii, Lactobacillus reuteri,
Lactobacillus fermentum and Bacteriodesokines
thetaomicron reduce pro-inflammatory cytokines.2–5
However, given the scope and complexity of
the microbiota as a whole, individual microbes
alone do not completely account for the true
capacity of the microbiota to attenuate or
promote inflammation. The complex relationships and the overall microenvironment of the
microbiota are vital to host health. The bacteria
in the microbiota are broadly categorized into
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three groups: commensal bacteria, symbiotic
bacteria and pathobiontic bacteria. Commensal bacteria do the host no harm but also do
not offer direct benefit. Meanwhile, symbiotic
bacteria offer direct benefit to the host (e.g.,
enzyme secretion and short chain fatty acid
[SCFA] production). Lastly, pathobiontic bacteria confer harm to the host.6 In this microenvironment, through competitive inhibition,
the commensals, symbionts and pathobionts
compete for nutrients and resources and prevent unchecked growth of any specific strains.7
Inflammation ensues when either the pathobiontic bacteria increase or the commensal
bacteria or symbiotic bacteria decrease. In this
event, the relative abundance of pathobiontic
bacteria becomes too great, which can create
an inflammatory-rich environment by triggering pro-inflammatory cytokines.6 Some factors
that contribute to this imbalance include antibiotic usage8 and poor diet.9
Potential pathologic sequelae of microbial
dysbiosis and chronic inflammation include
countless chronic illnesses. Increased levels of
pro-inflammatory cytokines due to microbial
dysbiosis have been observed amongst individuals with metabolic diseases, including obesity
and hypertension;10 renal diseases, like fatty
liver;11 as well as neurodegenerative diseases
and psychopathologies, such as Parkinson’s
disease,12 anxiety and depression.13

Nutrients

Given such far-reaching implications, targeted use of specific nutrients and dietary patterns can attenuate inflammation by restoring
gut health. Prebiotics are one such source of
nutrition that can help treat chronic illnesses.
Prebiotics are micronutrients that the human
body is unable to utilize in energy metabolism
and thereby promote a stable microbial environment by providing fuel for symbiotic bacteria. In doing so, symbiotic bacteria then produce a plethora of digestive enzymes as well as
short chain fatty acids (SCFAs). SCFAs act as
a fuel source for colonic enterocytes, as well as
enhance coordination between tight junctions,
thereby helping to maintain the integrity of the
epithelial wall.14 Absent of gut wall integrity,
increased intestinal permeability allows pathobiontic bacterial endotoxins such as lipopolysaccharides (LPS) to activate inflammatory
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cascades and has been associated with obesity
and insulin resistance.14 Furthermore, SCFAs
help to regulate hepatic glucose, modulate
appetite and aid in immune function.14
Increasing prebiotics in the diet is an effective
method of reaping the benefits of SCFA production by gut microbes. Common sources of
prebiotics include fiber and polyphenols. Fiber
intake should reach at least 30 grams daily.9
Food sources of fiber include legumes, whole
grains and resistant starches, such as sweet
potatoes and green bananas. Polyphenols, the
phytonutrients responsible for giving fruits and
vegetables their rich coloration can be found
abundantly in foods and beverages, such as apples, apricots, bilberries, black currant, broccoli,
red cabbage, white cabbage, cauliflower, fruit
juices, black tea and red wine.15 In sum, prebiotics provide the basis for a diverse and well-balanced microbial community by providing fuel
to symbionts, which promote health through
SCFA production.
However, research is beginning to shed light
on the potential for probiotics to attenuate inflammation and treat chronic illnesses as well.
Probiotics, literally meaning “for life,” include
microorganisms that, when administered in
adequate doses, can benefit the host. Probiotics can be ingested in many forms including
supplements; fermented foods like yoghurt,
kimchi and kefir; as well as foods fortified with
freeze-dried probiotics like breakfast cereals,
breads, crackers, granola bars, chocolate and
peanut butter.16
Some research suggests that L. reuteri
can reduce cholesterol in those with
hypercholesteremia.17 S. thermophilus, L.
bulgaricus, L acidophilus and B. longum seem to
decrease small intestinal permeability, as well
as improve mucosal barrier function.18 L. casei
and B. bifidum can improve body composition
among obese individuals.19 Additionally, a recent
meta-analysis found moderate effect sizes
across 105 studies for the use of probiotics
in improving chronic inflammation, obesity,
glucose control and fatty liver disease.20
Although these data seem promising, specific
prescriptions for the use of probiotics to
treat such illnesses have yet to be laid out.
Furthermore, as probiotics are considered
dietary supplements in the United States and
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are therefore not subject to FDA regulation or
oversight, it is difficult to ensure the quality
of the probiotic supplement regardless of
form.21 Future research should aim to establish
dosing recommendations in order to serve the
populations of individuals who are currently
affected by chronic illnesses.

Diet

Beyond the use of micronutrients, overall diet
patterns can also be effective in improving gut
health, reversing inflammation and treating
chronic illnesses. The Mediterranean diet has
been extensively studied and is lauded for its
ability to reduce pro-inflammatory cytokines.22
The Mediterranean diet is one rich in fruits,
vegetables, whole grains, beans and nuts. Red
meat is consumed sparingly; eggs, poultry
and fish are consumed weekly. Olive oil is the
primary cooking oil and red wine is consumed
in moderation.23 Not surprisingly, this diet is
inherently high in prebiotics like polyphenols
and fiber.
According to a recent meta-analysis by Ghosh
et al.,24 Mediterranean diet intake significantly
altered the abundance of specific gut bacteria.
Such changes were positively associated with
greater physical well-being, cognitive function
and anti-inflammatory cytokines; and were
negatively associated with pro-inflammatory
cytokines. The study concluded that Mediterranean diet adherence increases health-promoting bacteria and creates a stable microbial
environment, which is associated with improved health outcomes, such as decreased
inflammation.24
Unfortunately, the Mediterranean diet is, for
the most part, the opposite of the standard
American diet (SAD). While the Mediterranean
diet is rich in complex carbohydrates (e.g., prebiotics) and monounsaturated fats, the SAD is
laden with simple carbohydrates (e.g., sugar)
and saturated fats. While the Mediterranean
diet has been associated with numerous health
benefits, the SAD has been associated with
numerous health consequences. For example,
highly refined starches and sugar have been
shown to promote gut dysbiosis.9 Furthermore,
artificial sweeteners and emulsifiers that are
found in many processed foods have also been
shown to promote microbial dysbiosis.25,26 Giv-

en the sensitivity of the microbiota to diet, and
the consequences of dysbiosis, it is not surprising that the SAD is associated with higher
rates of inflammation.27
In line with the Mediterranean diet, the FDA’s
My Plate, (formerly the food pyramid) recommends that half of any given plate include
fruits and vegetables. The dietary recommendations also emphasize whole grains, and suggest that red meat be limited in favor of fish
and poultry.28 Taken together, diets resembling
Mediterranean style diets, which are inherently
high in prebiotics, can be an important consideration in treating a range of illnesses through
the attenuation of gut-mediated inflammation.

Summary

The vastly intricate and complex gut microbiota
plays an important role in the promotion of human health. States of dysbiosis contribute to
chronic systemic inflammation and ultimately,
pathology. Fortunately, nutrition both in terms
of micro- and macro-nutrient patterns serve
as a viable strategy to address inflammation
and treat chronic illnesses that currently affect
such a significant portion of the population.
Diabetes is the seventh leading cause of death
in the United States; type 2 diabetes accounts
for over 90% of all diagnosed cases of diabetes. According to the Centers for Disease
Control and Prevention,1 30.3 million people in
the U.S. have diabetes and an estimated 7.2
million are believed to be living with undiagnosed diabetes. At the same time, 84.1 million
people are at increased risk for developing type
2 diabetes. Thus, more than 114 million Americans are at risk for developing the devastating complications of diabetes. The American
Diabetes Association2 estimated the total cost
of diabetes in the United States in 2012 at $245
billion, and the average medical expenditures
for people with diagnosed diabetes at about
$13,700 per year. After adjusting for age group
and sex, average medical expenditures among
people with diagnosed diabetes were about
2.3 times higher than expenditures for people
without diabetes.
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